The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 Study
- PMID: 38455741
- PMCID: PMC10915439
- DOI: 10.21037/tp-23-536
The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 Study
Keywords: Homoharringtonine (HHT); leukemia; maintenance; myeloid.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-536/coif). The authors have no conflicts of interest to declare.
Comment on
-
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.J Clin Oncol. 2023 Nov 1;41(31):4881-4892. doi: 10.1200/JCO.22.02836. Epub 2023 Aug 2. J Clin Oncol. 2023. PMID: 37531592 Free PMC article. Clinical Trial.
Similar articles
-
Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):13-21. doi: 10.1016/j.clml.2014.09.011. Epub 2014 Oct 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25458084 Review.
-
The efficacy and safety of a homoharringtonine-based protocol for children with acute myeloid leukemia: A retrospective study in China.Pediatr Hematol Oncol. 2021 Mar;38(2):97-107. doi: 10.1080/08880018.2020.1820649. Epub 2020 Oct 5. Pediatr Hematol Oncol. 2021. PMID: 33016804
-
Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells.Exp Cell Res. 2019 Mar 15;376(2):114-123. doi: 10.1016/j.yexcr.2019.02.008. Epub 2019 Feb 11. Exp Cell Res. 2019. PMID: 30763586
-
Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.Biochem Pharmacol. 2021 Jun;188:114538. doi: 10.1016/j.bcp.2021.114538. Epub 2021 Apr 6. Biochem Pharmacol. 2021. PMID: 33831397
-
Efficacy and Safety of Homoharringtonine for the Treatment of Acute Myeloid Leukemia: A Meta-analysis.Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):e752-e767. doi: 10.1016/j.clml.2021.06.002. Epub 2021 Jun 9. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34301487 Review.
Cited by
-
Characterization of Acute Myeloid Leukemia With RUNX1/RUNX1T1 Gene Rearrangement: Clinical, Hematological, and Morphological Features.Cureus. 2024 Nov 29;16(11):e74760. doi: 10.7759/cureus.74760. eCollection 2024 Nov. Cureus. 2024. PMID: 39735012 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources